Skip to main content
logo
CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.77
+0.08 (1.04%)
At close: Sep 24, 2026, 4:00 PM EDT
7.80
+0.03 (0.39%)
Pre-market: Sep 25, 2026, 4:19 AM EDT

CorMedix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
462.25311.7143.47-0.070.19
Revenue Growth
280.50%617.03%---65.74%-20.19%
Gross Profit
417.01289.6240.44-0.060.04
Operating Income
227.24160.34-22.36-48.96-30.62-29.44
Net Income
186.02162.07-17.93-46.34-29.7-28.21
Earnings Per Share
2.082.04-0.30-0.91-0.74-0.75
EPS Growth
163.53%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
256.69158.951.6976.0358.7965.47
Total Debt
147.46148.910.520.670.80.92
Net Cash (Debt)
109.249.9851.1775.3657.9964.54
Net Cash Growth
-42.59%-80.50%-32.10%29.96%-10.15%42.43%
Net Cash Per Share
1.200.120.871.481.441.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
253.94175.05-50.62-38.41-24.36-21.16
Capital Expenditures
-3.52-2.26-0.12-0.33-0.22-1.43
Free Cash Flow
250.42172.79-50.73-38.74-24.58-22.58
Free Cash Flow Growth
723.50%-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.21%92.91%93.02%-94.29%22.00%
Operating Margin
49.16%51.44%-51.43%--46819.91%-15417.51%
Pretax Margin
44.00%48.13%-44.45%--46305.23%-15429.47%
Profit Margin
40.24%51.99%-41.24%--45409.90%-14774.70%
FCF Margin
54.17%55.43%-116.70%--37573.53%-11826.24%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.735.65----
Forward PE
-4.1512.27---
P/FCF Ratio
2.425.30----
PS Ratio
1.312.9411.31-2662.04907.08